Swapnali A. Thorat
Research Subjects
Swapnali A. Thorat has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Ashish A. Misal1 shared publication
Atul R. Chopade
Rajarambapu College of Pharmacy, Kasegaon, Sangli, Maharashtra, 415404, India
1 shared publicationBapu R. Thorat
Department of Chemistry, P.G. and Research Centre, Government of Maharashtra’s Ismail Yusuf College, Jogeshwari, Mumbai, India
1 shared publicationBrijmohan Agrawal
Maulana Azad College, Aurangabad, (M.S.), India
1 shared publication- Dnyaneshwar T. Nagre
Department of Chemistry, Rashtramata Indira Gandhi College, Jalna, Ahmednagar (M.S.), India
1 shared publication - Ganesh H. Wadkar1 shared publication
Latest Publications
- Open Access
- 30 May 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 1361-1371
Design and Evaluation of Phyto-phospholipid Complexes of Selected Polyherbal Churna Extracts for Anticancer Activity
Background: Cancer continues to be a global health problem today. Traditional chemotherapy, which is commonly used in the treatment of cancer, has problems like low bioavailability, systemic toxicity, and drug resistance. Polyherbal formulations provide synergistic therapeutic advantages, whereas phyto-phospholipid complexation improves the solubility, permeability, and bioavailability of phytoconstituents. Aim: To develop and evaluate phyto-phospholipid complexes from a specific polyherbal churna extract that includes Picrorhiza kurroa, Bauhinia variegata, and Curcuma longa to boost their anticancer effects. Methods: A hydroalcoholic extract of polyherbal churna was prepared by maceration. Phyto-phospholipid complexes were prepared using the solvent evaporation method at different drug-phospholipid ratios (1:1, 1:2, and 1:3). Particle size analysis, Fourier Transform Infrared Spectroscopy (FTIR), X-Ray Diffraction (XRD), Digital Signature Certificate (DSC), and zeta potential determination were used to characterise the optimised complex. The DPPH and ABTS tests were used to see how well the antioxidants worked. The MTT assay was used to assess how toxic the cells were to HeLa, MCF-7, and A549 cancer cell lines. Results: Enhanced solubility and entrapment efficiency of 78.45 ± 2.3% were demonstrated by the optimised phyto-phospholipid complex (1:2 ratios). Complex formation was verified by FTIR and DSC. With IC50 values of 24.8 ± 1.5 μg/mL (DPPH) and 28.3 ± 1.8 μg/mL (ABTS), the complex outperformed crude extract in terms of antioxidant activity (IC50: 45.2 ± 2.1 and 52.6 ± 2.4 μg/mL, respectively). Comparing the complex to crude extract, cytotoxicity studies showed significantly lower IC50 values against MCF-7 (32.5 ± 2.1 μg/mL), HeLa (38.7 ± 2.5 μg/mL), and A549 (42.3 ± 2.8 μg/mL). Conclusion: Polyherbal churna extract phyto-phospholipid complexes showed increased antioxidant and cytotoxic potential, suggesting potential for cancer treatment and calling for additional in vivo research. Major Findings: The optimized complex (1:2 ratio) showed 5-fold enhanced solubility, 45% stronger antioxidant activity (IC₅₀: 24.8 vs 45.2 μg/mL), and two-fold improved cytotoxicity against cancer cell lines (IC₅₀: 32.5-42.3 vs 68.5-82.7 μg/mL) compared to crude extract, as confirmed by comprehensive characterization (FTIR, DSC, XRD, SEM, TEM).
- 30 May 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 1361-1371
Open AccessDesign and Evaluation of Phyto-phospholipid Complexes of Selected Polyherbal Churna Extracts for Anticancer Activity
Background: Cancer continues to be a global health problem today. Traditional chemotherapy, which is commonly used in the treatment of cancer, has problems like low bioavailability, systemic toxicity, and drug resistance. Polyherbal formulations provide synergistic therapeutic advantages, whereas phyto-phospholipid complexation improves the solubility, permeability, and bioavailability of phytoconstituents. Aim: To develop and evaluate phyto-phospholipid complexes from a specific polyherbal churna extract that includes Picrorhiza kurroa, Bauhinia variegata, and Curcuma longa to boost their anticancer effects. Methods: A hydroalcoholic extract of polyherbal churna was prepared by maceration. Phyto-phospholipid complexes were prepared using the solvent evaporation method at different drug-phospholipid ratios (1:1, 1:2, and 1:3). Particle size analysis, Fourier Transform Infrared Spectroscopy (FTIR), X-Ray Diffraction (XRD), Digital Signature Certificate (DSC), and zeta potential determination were used to characterise the optimised complex. The DPPH and ABTS tests were used to see how well the antioxidants worked. The MTT assay was used to assess how toxic the cells were to HeLa, MCF-7, and A549 cancer cell lines. Results: Enhanced solubility and entrapment efficiency of 78.45 ± 2.3% were demonstrated by the optimised phyto-phospholipid complex (1:2 ratios). Complex formation was verified by FTIR and DSC. With IC50 values of 24.8 ± 1.5 μg/mL (DPPH) and 28.3 ± 1.8 μg/mL (ABTS), the complex outperformed crude extract in terms of antioxidant activity (IC50: 45.2 ± 2.1 and 52.6 ± 2.4 μg/mL, respectively). Comparing the complex to crude extract, cytotoxicity studies showed significantly lower IC50 values against MCF-7 (32.5 ± 2.1 μg/mL), HeLa (38.7 ± 2.5 μg/mL), and A549 (42.3 ± 2.8 μg/mL). Conclusion: Polyherbal churna extract phyto-phospholipid complexes showed increased antioxidant and cytotoxic potential, suggesting potential for cancer treatment and calling for additional in vivo research. Major Findings: The optimized complex (1:2 ratio) showed 5-fold enhanced solubility, 45% stronger antioxidant activity (IC₅₀: 24.8 vs 45.2 μg/mL), and two-fold improved cytotoxicity against cancer cell lines (IC₅₀: 32.5-42.3 vs 68.5-82.7 μg/mL) compared to crude extract, as confirmed by comprehensive characterization (FTIR, DSC, XRD, SEM, TEM).
- 1 July 2021
- Published by Bentham Science Publishers Ltd. in Current Enzyme Inhibition
- Vol. 17 (2) , 127-143
Synthesis, In-Silico Potential Enzymatic Target Predictions, Pharmacokinetics, Toxicity, Anti-Microbial and Anti-Inflammatory Studies of Bis-(2-methylindolyl) Methane Derivatives
Background: The bis(indolyl)methanes (BIMs) scaffold is reported for wide varieties of pharmacological profiles, including antibacterial, anti-proliferative, anticancer, cytotoxic, insecticidal, analgesic, antioxidant, and anti-inflammatory agents. Materials and Methods: A series of bis(indolyl)methanes have been synthesized by a greener and newer approach using the reaction of different substituted aldehydes and indole in the presence of an easily available and biodegradable base such as piperidine in acetic acid at room temperature and characterized with ultraviolet–visible spectrophotometry (UV–Vis or UV/Vis), Fourier-transform infrared spectroscopy (FTIR), nuclear magnetic resonance spectroscopy (NMR), etc. The antibacterial and antifungal activities were also carried out against Staphylococcus aureus (RCMB 000106) and Bacillis subtilis (RCMB 000107), as two Gram-positive bacterial strains, and Salmonella typhi and Escherichia coli (RCMB 000103), as two Gram-negative bacterial strains. Fungal species such as Candida Albicans, Penicillium chrysogenum, Aspergillus niger were also used for in vitro antifungal evaluation. All our newly synthesized 14 compounds (4a-4n) were subjected for anti-inflammatory activity in vitro and compared with the known standard drug aceclofenac. Results: Our newly synthesized compounds showed good to moderate antibacterial agents, in silico ADMET, and anti-inflammatory profiles. Conclusion: We hope that our current study would aid future developments of bis(indolyl)methanes as antibacterial and anti-inflammatory agents.
- 1 July 2021
- Published by Bentham Science Publishers Ltd. in Current Enzyme Inhibition
- Vol. 17 (2) , 127-143
Synthesis, In-Silico Potential Enzymatic Target Predictions, Pharmacokinetics, Toxicity, Anti-Microbial and Anti-Inflammatory Studies of Bis-(2-methylindolyl) Methane Derivatives
Background: The bis(indolyl)methanes (BIMs) scaffold is reported for wide varieties of pharmacological profiles, including antibacterial, anti-proliferative, anticancer, cytotoxic, insecticidal, analgesic, antioxidant, and anti-inflammatory agents. Materials and Methods: A series of bis(indolyl)methanes have been synthesized by a greener and newer approach using the reaction of different substituted aldehydes and indole in the presence of an easily available and biodegradable base such as piperidine in acetic acid at room temperature and characterized with ultraviolet–visible spectrophotometry (UV–Vis or UV/Vis), Fourier-transform infrared spectroscopy (FTIR), nuclear magnetic resonance spectroscopy (NMR), etc. The antibacterial and antifungal activities were also carried out against Staphylococcus aureus (RCMB 000106) and Bacillis subtilis (RCMB 000107), as two Gram-positive bacterial strains, and Salmonella typhi and Escherichia coli (RCMB 000103), as two Gram-negative bacterial strains. Fungal species such as Candida Albicans, Penicillium chrysogenum, Aspergillus niger were also used for in vitro antifungal evaluation. All our newly synthesized 14 compounds (4a-4n) were subjected for anti-inflammatory activity in vitro and compared with the known standard drug aceclofenac. Results: Our newly synthesized compounds showed good to moderate antibacterial agents, in silico ADMET, and anti-inflammatory profiles. Conclusion: We hope that our current study would aid future developments of bis(indolyl)methanes as antibacterial and anti-inflammatory agents.
- 15 June 2020
- Published by Science Alert in Research Journal of Medicinal Plant
- Vol. 14 (3) , 133-143
In-silico Evaluation of Wound Healing Potential of Euphorbia tithymaloides
In-silico Evaluation of Wound Healing Potential of Euphorbia tithymaloides
- 15 June 2020
- Published by Science Alert in Research Journal of Medicinal Plant
- Vol. 14 (3) , 133-143
In-silico Evaluation of Wound Healing Potential of Euphorbia tithymaloides
In-silico Evaluation of Wound Healing Potential of Euphorbia tithymaloides